Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
4.2 HM-15275 - Hanmi Pharmaceutical What it is
What Eli Lilly Actually Does (and Why India Matters to It) Eli Lilly and Company is a US-based pharmaceutical major focused on diabetes, obesity, oncology, immunology, and neuroscience, with a portfolio that includes tirzepatide (Mounjaro/Zepbound), abemaciclib (Verzenio), and multiple insulin products
It can be used up to 10% worldwide except for the US and Canada
Coverage unavailable when GLP-1 coverable under Part D benefit Beneficiaries who are prescribed Wegovy or Zepbound for a use that is coverable under the basic Medicare Part D benefit, regardless of whether the drug is on the Part D plans formulary (e.g., Zepbound for the treatment of moderate to severe obstructive sleep apnea in adults with obesity, or Wegovy to reduce the risk of major adverse cardiovascular (CV) events in adults with established CV disease who are either obese or overweight), will not qualify for coverage of that drug under the Bridge Program
US$ 29.43
US$ 24.51
US$ 27.65
US$ 22.00
